Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-21-000603

Options or other derivatives

  • Director acquired 4,620 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Miller Joseph M · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +4,620 4,620 D
Loading xslF345X03/edgar.xml…